Penumbra designs, develops, and manufactures interventional medical devices for neurovascular and vascular conditions. Founded in 2004 and headquartered in Alameda, California, the company operates across 100+ markets with over 4,500 employees. Its product portfolio includes thrombectomy systems for clot removal in stroke patients, embolization technologies for vascular occlusion procedures, and the Lightning Flash system for pulmonary embolism treatment. The neurovascular device line addresses conditions requiring catheter-based interventions in the brain's blood vessels.
The company's technical scope extends beyond traditional catheter-based devices into rehabilitation technology through its REAL immersive healthcare platform. This represents a systems integration challenge spanning mechanical device design, catheter navigation under fluoroscopic guidance, and closed-loop rehabilitation protocols. Manufacturing operations handle precision componentry for devices that must maintain performance tolerances while navigating tortuous vascular anatomy, requiring expertise in materials selection, fixture design, and process validation under FDA quality management systems.
Penumbra's engineering work addresses constraints inherent to intravascular intervention: device profiles measured in fractions of millimeters, navigation through vessels with complex geometry, and operation under real-time imaging with limited feedback. Product development cycles must account for biocompatibility testing, sterilization validation, and clinical trial protocols before commercial deployment. The manufacturing pipeline processes components through cleanroom environments with documented traceability and statistical process control.